Cardiorenal Metabolic Syndrome: MRAs and Potassium Binders

Drs Nihar Desai, Andrew J. Sauer, and Matthew A. Sparks discuss novel therapies in cardiorenal metabolic syndrome, focusing in on the MRAs and potassium binders.
Relevant disclosures can be found with the episode show notes on Medscape www.medscape.c.... The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
The Kidney Failure Risk Equation: Evaluation of Novel Input Variables Including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts pubmed.ncbi.nl...
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association pubmed.ncbi.nl...
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease pubmed.ncbi.nl...
Heart Failure in Patients With Chronic Kidney Disease pubmed.ncbi.nl...
Lokelma Prescribing Information den8dhaj6zs0e....
Sodium Zirconium Cyclosilicate in Hyperkalemia pubmed.ncbi.nl...
Veltassa Prescribing Information veltassa.com/pi
Patiromer for the Management of Hyperkalemia in Heart Failure With Reduced Ejection Fraction: The DIAMOND Trial pubmed.ncbi.nl...
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics pubmed.ncbi.nl...
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes pubmed.ncbi.nl...
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial pubmed.ncbi.nl...
Press Release: First Patient Enrolled in CARE-HK in HF to Evaluate Role of Veltassa® (Patiromer) in Enabling RAASi Treatment newsroom.csl.c...
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry pubmed.ncbi.nl...
Finerenone in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial pubmed.ncbi.nl...
Additional Studies With Finerenone Across a Wide Range of Heart Failure Patients Initiated www.bayer.com/...
Treatment Effects of Empagliflozin in Hospitalized Heart Failure Patients Across the Range of Left Ventricular Ejection Fraction - Results From the EMPULSE Trial pubmed.ncbi.nl...
Safety, Tolerability and Efficacy of Up-Titration of Guideline-Directed Medical Therapies for Acute Heart Failure (STRONG-HF): A Multinational, Open-Label, Randomised, Trial pubmed.ncbi.nl...
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTs pubmed.ncbi.nl...